TORNTPHARM - Swing Trade Analysis with AI Signals

Last Updated Time : 05 Nov 25, 7:43 am

Swing Trade Rating: 4.2

📊 TORNTPHARM shows strong fundamentals and stable technical indicators, making it a solid swing trade candidate. Optimal entry is ₹3,550–₹3,570. If already held, consider exiting near ₹3,650–₹3,700.

📈 Positive

• ROCE (27.8%) and ROE (26.2%) reflect excellent capital efficiency and profitability.
• MACD (6.49) is positive, indicating bullish momentum.
• Volume above 1-week average suggests growing market interest.
• Quarterly PAT growth of 17.5% shows consistent earnings improvement.
• Trading above 200-DMA (₹3,398) and near 50-DMA (₹3,566) supports technical strength.

⚠️ Limitation

• High P/E (60.9) compared to industry average (33.1) implies premium valuation.
• PEG ratio (2.50) suggests expensive pricing relative to growth.
• RSI (49.6) is neutral, offering limited oversold advantage.
• Dividend yield (0.90%) is modest for income-focused investors.

🚫 Company Negative News

• FII holdings declined by 0.17%, showing slight reduction in foreign investor confidence.
• Stock trading near recent highs may limit short-term upside.

✅ Company Positive News

• DII holdings increased by 0.63%, showing strong domestic institutional support.
• EPS of ₹58.2 and consistent profitability reinforce long-term strength.
• Strong performance in branded generics and specialty pharma segments.

🌐 Industry

• TORNTPHARM operates in the pharmaceutical sector, which benefits from defensive demand and innovation-driven growth.
• Industry P/E of 33.1 reflects moderate valuation expectations.

🧾 Conclusion

• TORNTPHARM is a strong swing trade candidate with solid fundamentals and technical support.
• Optimal entry: ₹3,550–₹3,570 (near 50-DMA and support zone).
• Exit target: ₹3,650–₹3,700 (near resistance and psychological level).
• Monitor MACD continuation and volume strength for confirmation.

I can chart TORNTPHARM’s RSI and MACD trends to help you visualize the timing for entry and exit.